Login Contact Us
E-ISSN : 2148-9696
Crescent Journal of
Medical and Biological Sciences
Jan 2019, Vol 6, Issue 1
Advanced Search
Title
Authors
Keyword
Poll
How do you find the scientific quality of the published articles on our web site?
Review
A New Treatment Method Agent in Hepatocellular Carcinoma (HCC) By MicroRNAS
Zahra Asefy1, Naser Samadi1, Alireza Abhari1, Behrooz Shokuhi1, Saeed Nazare2, Mohammad Noori1, Sirus Hoseinnejhad3
1Department of Clinical Biochemistry ,Tabriz Medicine University,Student research Committee Tabriz-Iran
2Department of Clinical Biochemistry department Tabriz Medicine University, Digestive and Liver Research Center,Tabriz-Iran
3Department of Biochemistry, Marageh Medical university ,Marageh ,Iran. Baki Devlet university_Baki Azerbaycan


Viewed : 22 times
Downloaded : times.

Keywords : Hepato cellular carcinoma (HCC), miRNA, Molecular targets
| Related Articles
Abstract

Objectives :The most incidence form of cancer in the human liver and the main reason for worldwide cancer death is Hepatocellular carcinoma (HCC).HCC is common form of cancer in Africa and Asia. HCC is a global health issue. Efforts to improve treatment strategies and prognosis in HCC to recognize novel prognostic and predictive markers should be investigated

Materials and Methods :We reviewed recently published studies identified from National Institutes of Health's PubMed database , Latin American Literature in Health Sciences (Lilacs), Scientific Electronic Library Online (SciELO). key search terms consisting of hepatocellular carcinoma” AND “diagnosis” AND “hepatic resection”,miRNA, and Mesh (Medical Subject Headings) consisting of miRNA“hepatocellular carcinoma.

Results:Both physiological and pathological processes such as development can be altered by function and expression modifying of miRNA. current research has been considered that miR-101, miR-106, miR-130a, miR- 515 -5p, miR-199a, and miR- 34a -5p which have a considerable connection with tumor size in HCC patients.

Conclusion:Several reports indicating more than half of the miRNAs genes are located in cancer-associated genomic regions or in fragile sites.As the miRNAs important roles of in cancer are reported, their potential as prognostic or diagnostics markers is evidenced by a long list of studies. miRNA markers that could be used for cancer diagnosis are becoming available

 

Cite By, Google Scholar

Google Scholar

Articles by Asefy Z
Articles by Samadi N
Articles by Abhari A
Articles by Shokuhi B
Articles by Nazare S
Articles by Noori M
Articles by Hoseinnejhad S

PubMed

Articles by Zahra Asefy
Articles by Naser Samadi
Articles by Alireza Abhari
Articles by Behrooz Shokuhi
Articles by Saeed Nazare
Articles by Mohammad Noori
Articles by Sirus Hoseinnejhad

Submit Paper
Online Submission System
CJMB ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Publisher
Aras Part Medical International Press Editors in Chief
Arash Khaki
Editor
Zafer Akan Deputy Editor
Javadi, Leila
Published Article Statistics